PBS funding for vigabatrin substitution

pharmacy intern
PBS confirms subsidy arrangements for vigabatrin under a serious scarcity substitution instrument (SSSI)  An amendment to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 to enable Pharmaceutical Benefits Scheme (PBS) subsidies for the supply of different forms of vigabatrin under an SSSI.  The Therapeutic Goods Administration (TGA) announced

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Limited uptake of 60-day scripts
Next Overcoming the language barrier